Jayanth G Rao, MD | |
3406 N Lecanto Hwy., Suite A, Beverly Hills, FL 34465-3548 | |
(352) 746-1100 | |
(352) 422-7023 |
Full Name | Jayanth G Rao |
---|---|
Gender | Male |
Speciality | Radiology - Radiation Oncology |
Location | 3406 N Lecanto Hwy., Beverly Hills, Florida |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1528053162 | NPI | - | NPPES |
25903 | Other | FL | BCBS OF FL |
103495 | Other | FL | AVMED |
25903 | Other | FL | BCBS |
P00056 | Other | FL | FREEDOM HEALTH |
P00909691 | Other | FL | RR MEDICARE |
P01254190 | Other | FL | RAILROAD MCR |
P201226 | Other | FL | OPTIMUM |
2486569 | Other | FL | CIGNA |
5002104 | Other | FL | AETNA |
P502641 | Medicaid | FL | |
346441900 | Medicaid | FL | |
937635 | Other | FL | WELLCARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0001X | Radiology - Radiation Oncology | ME 65465 (Florida) | Primary |
Mailing Address | Practice Location Address |
---|---|
Jayanth G Rao, MD 2234 Colonial Blvd, Attn: Payer Contracting & Relations, Fort Myers, FL 33907-1412 Ph: (239) 931-7342 | Jayanth G Rao, MD 3406 N Lecanto Hwy., Suite A, Beverly Hills, FL 34465-3548 Ph: (352) 746-1100 |
News Archive
A new study by a NewYork-Presbyterian Hospital/Weill Cornell Medical Center physician-scientist has an important message for the elderly: It's not too late to improve your health through diet and exercise, even if you've had an unhealthy lifestyle in the past!
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the Thermo Scientific Nunc Edge 96-well Plates for cell-based assays.
Doctors can use either an artery in the arm (the radial approach) or in the groin (the femoral approach) to safely perform percutaneous coronary intervention (PCI) on patients presenting with a heart attack, according to research presented at the American College of Cardiology's 68thAnnual Scientific Session. The research, which was stopped early, suggests the radial and femoral approach are equivalent in terms of the risk of death at 30 days.
Enzo Biochem, Inc. today reported improved sequential results for the first fiscal quarter ended October 31, 2010, the result of recent programs to reduce expenses, consolidate activities and expand operations.
Scientists from Uppsala University, the Science for Life Laboratory in Stockholm and Uppsala University Hospital have developed a new method of rapidly identifying which bacteria are causing an infection and determining whether they are resistant or sensitive to antibiotics.
› Verified 7 days ago